跳至主要内容
临床试验/CTRI/2020/10/028396
CTRI/2020/10/028396尚未招募不适用

Effect of Diabetic Retinopathy and its treatment on Macular Capillary Network Density

Sankara Eye Hospital Bangalore1 个研究点 分布在 1 个国家目标入组 126 人开始时间: 2020年10月17日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
126
试验地点
1
主要终点
To assess changes in the Macular Capillary Vessel Density in patients with Diabetic Retinopathy and following treatment

研究概览

简要总结

India is diabetic capital of world, with prevalence reaching nearly 70 million by 2025. Diabetes mellitus (DM) is a chronic metabolic disorder with several related systemic complication. Diabetic retinopathy (DR) is a common and specific microvascular complication of DM. Incidence of DR is on a rise and it nearly affects one third of patients with DM.

DR is a microangiopathy characterized by pericyte loss, thickening of basement membrane, formation of microaneurysms, and breakdown of blood retinal barrier.

These microvascular changes leads to capillary occulsion thereby causing retinal non-perfusion.

DR is the leading cause of preventable blindness and early detection and treatment is the only means of preventing it. Optical Coherence Tomography Angiography(OCTA) is a new imaging modality, which can detect these retinal microvascular changes at an early stage even before it’s clinical manifestation.

In our study we would quantify these changes in macular capillary vessel density in diabetic patients as compared to healthy population and also if any change is seen following specific DR treatment. And also  assess the  association between vessel density and visual acuity and that with levels of HbA1c and changes in the central retinal thickness.

研究设计

研究类型
Observational

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients within Age group of 30 years to 60 years 2.Patients with Non-Proliferative Diabetic Retinopathy (NPDR)(Both Type1 and Type2 Diabetes Mellitus)
  • Patients with Diabetes with no evidence of Diabetic Retinopathy 4.Patients with NPDR with Centre involving Macular Edema undergoing treatment.

排除标准

  • Patients with Proliferative Diabetic Retinopathy(PDR)
  • Patients with Non-centre involving Macular Edema
  • Clinical evidence of other ocular or retinal pathology
  • Patients undergone previous treatment(Intravitreal injection or laser)
  • Patients with diabetic Tractional retinal detachement or Complete retinal detachment (TRD/CRD).

结局指标

主要结局

To assess changes in the Macular Capillary Vessel Density in patients with Diabetic Retinopathy and following treatment

时间窗: baseline and 6 months

次要结局

  • 1. To assess if there is any association between vessel density and HbA1c levels(2. To evaluate association of vessel density with visual acuity)

研究者

发起方
Sankara Eye Hospital Bangalore
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验